# Qiang Lu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/qiang-lu-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 807 |
| Field | Esophageal Cancer Research and Treatment |
| h-index | 16 |
| i10-index | 27 |
| Last Known Institution | Changchun Institute of Biological Products |
| OpenAlex ID | https://openalex.org/A5101898965 |
| ORCID iD | 0000-0002-3155-0107 |
| Works | 67 |

## Researcher papers

- [Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells](https://scholariq.org/papers/phase-1-clinical-trial-demonstrated-that-muc1-positive-metastatic-seminal/)
- [TFAP2A potentiates lung adenocarcinoma metastasis by a novel miR-16 family/TFAP2A/PSG9/TGF-β signaling pathway](https://scholariq.org/papers/tfap2a-potentiates-lung-adenocarcinoma-metastasis-by-a-novel-mir-16-family/)
- [Efficacy and complications of cataract surgery in high myopia](https://scholariq.org/papers/efficacy-and-complications-of-cataract-surgery-in-high-myopia/)
- [Subxiphoid and subcostal arch “Three ports” thoracoscopic extended thymectomy for myasthenia gravis](https://scholariq.org/papers/subxiphoid-and-subcostal-arch-three-ports-thoracoscopic-extended-thymectomy-for/)
- [Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases](https://scholariq.org/papers/sleep-disorders-in-leucine-rich-glioma-inactivated-protein-1-and-contactin/)
- [Lens Opacities Classification System III–based artificial intelligence program for automatic cataract grading](https://scholariq.org/papers/lens-opacities-classification-system-iii-based-artificial-intelligence-program/)
- [Early transient intraocular pressure spike after cataract surgery in highly myopic cataract eyes and associated risk factors](https://scholariq.org/papers/early-transient-intraocular-pressure-spike-after-cataract-surgery-in-highly/)
- [A polymorphism in CALHM1 is associated with temporal lobe epilepsy](https://scholariq.org/papers/a-polymorphism-in-calhm1-is-associated-with-temporal-lobe-epilepsy/)
- [Acquired rare recurrent <i>EGFR</i> mutations as mechanisms of resistance to Osimertinib in lung cancer and <i>in silico</i> structural modelling.](https://scholariq.org/papers/acquired-rare-recurrent-i-egfr-i-mutations-as-mechanisms-of-resistance-to/)
- [Complicated paroxysmal kinesigenic dyskinesia associated with SACS mutations](https://scholariq.org/papers/complicated-paroxysmal-kinesigenic-dyskinesia-associated-with-sacs-mutations/)

## Researcher topics

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Autoimmune Neurological Disorders and Treatments](https://scholariq.org/topics/autoimmune-neurological-disorders-and-treatments/)
- [Ophthalmology and Visual Impairment Studies](https://scholariq.org/topics/ophthalmology-and-visual-impairment-studies/)
- [Intraocular Surgery and Lenses](https://scholariq.org/topics/intraocular-surgery-and-lenses/)
- [Pleural and Pulmonary Diseases](https://scholariq.org/topics/pleural-and-pulmonary-diseases/)

## Researcher university

- [Changchun Institute of Biological Products](https://scholariq.org/institutions/changchun-institute-of-biological-products/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.